Mingxin New Material (605068.SH) plans to reduce its shareholding by no more than 2%.

21:11 03/04/2026

Mingxin Xuteng (605068.SH) announced that on April 3, 2026, the company received a notification letter from Mingxin Assets regarding the plan to reduce its holdings of shares in Mingxin Xuteng New Materials Co., Ltd. The notice stated that Mingxin Assets will reduce its holdings of the company's shares through block trading within 3 months after 15 trading days from the date of the announcement (April 28, 2026 to July 27, 2026), with the total amount not exceeding 3.244 million shares, representing no more than 2% of the company's total share capital.

Mingxin New Material (605068.SH) announced that on April 3, 2026, the company received a notice from Mingxin Assets regarding their plan to reduce their holdings of Mingxin New Material Limited shares. Mingxin Assets plans to reduce their total holdings by no more than 3.24 million shares, representing less than 2% of the company's total share capital, through block trades within 3 months after 15 trading days from the date of the announcement (April 28, 2026- July 27, 2026).

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!

JP Morgan: AI demand "bursting" advanced process Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) Q1 gross margin may exceed expectations.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!

JP Morgan: AI demand "bursting" advanced process Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) Q1 gross margin may exceed expectations.